Patents by Inventor Matthew Winkler

Matthew Winkler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020115841
    Abstract: The present invention is directed to compositions and methods for removal of nucleic acid probes from sample nucleic acids, particularly when the sample nucleic acids are attached to a solid support. The invention also concerns methods of stripping and reusing nucleic acid blots.
    Type: Application
    Filed: February 25, 2002
    Publication date: August 22, 2002
    Inventors: David Brown, Matthew Winkler
  • Publication number: 20020055162
    Abstract: The present invention relates to compositions and methods for increasing the yields of polynucleotide synthetic reactions. In particular, it relates to an improved reaction mixture for use in in vitro RNA trancription and in various other enzymatic reactions in which a polynucleotide is synthesised. The reaction mixture uses high concentrations of total nucleotides, in the order of 12 mM to 40 mM, i.e. levels that were previously thought to be inhibitory. Other useful modifications are also disclosed.
    Type: Application
    Filed: September 28, 2001
    Publication date: May 9, 2002
    Applicant: Ambion, Inc.
    Inventors: Susan C. Milburn, Marianna Goldrick, Matthew Winkler
  • Patent number: 6365731
    Abstract: The present invention is directed to compositions and methods for removal of nucleic acid probes from sample nucleic acids, particularly when the sample nucleic acids are attached to a solid support. The invention also concerns methods of stripping and reusing nucleic acid blots.
    Type: Grant
    Filed: August 6, 1997
    Date of Patent: April 2, 2002
    Assignee: Ambion, Inc.
    Inventors: David Brown, Matthew Winkler
  • Patent number: 6214982
    Abstract: The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: April 10, 2001
    Inventors: Brittan L. Pasloske, Dwight DuBois, David Brown, Matthew Winkler
  • Patent number: 6057134
    Abstract: The invention relates to modified oligonucleotide primers used to adjust the amplification efficiency of an abundant target without affecting the amplification of other targets in a DNA synthesis reaction. The invention may be used in PCR.TM. or any other primer dependent DNA transcription technology.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: May 2, 2000
    Assignee: Ambion, Inc.
    Inventors: Eric S. Lader, Marianna Goldrick, Matthew Winkler
  • Patent number: 5939262
    Abstract: The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.
    Type: Grant
    Filed: June 24, 1997
    Date of Patent: August 17, 1999
    Assignees: Ambion, Inc., Cenetron Diagnostics, LLC
    Inventors: Brittan L. Pasloske, Dwight DuBois, David Brown, Matthew Winkler
  • Patent number: 5589329
    Abstract: The present invention discloses improved compositions and methods for detecting mutations, including single base changes, in nucleic acid sequences using RNase protection assays. The improvements include concomitant, dramatic reductions in the salt and RNase enzyme concentrations in the RNase digestion reaction mixture which result in greater sensitivity in detecting genetic mutations. Another embodiment of the present invention is kits to be used for the detection of single base mismatches in nucleic acid samples.
    Type: Grant
    Filed: November 15, 1993
    Date of Patent: December 31, 1996
    Assignee: Ambion, Inc.
    Inventors: Matthew Winkler, Marianna M. Goldrick
  • Patent number: 5547862
    Abstract: Disclosed are novel DNA segments, vectors and plasmids containing multiple promoters for use with various polymerases in order to transcribe cloned DNA into RNA. A preferred vector, termed pTRIPLEscript.TM., is described which contains the SP6, T7, and T3 phage promoters in the same orientation and on the same side of a multiple cloning site. This vector efficiently synthesizes in vitro transcripts from all three promoters under conditions of both limiting and saturating nucleotide concentrations. This vector also promotes transcription without crosstalk, i.e., without nonspecific initiation at inappropriate promoters.
    Type: Grant
    Filed: July 29, 1993
    Date of Patent: August 20, 1996
    Assignee: Ambion Inc.
    Inventors: James Meador, Hoyt E. McElroy, Michelle L. Herrmann, Matthew Winkler
  • Patent number: 5422241
    Abstract: A method for the recovery of nucleic acids from a reaction mixture, such as nuclease protection assays, comprising the use of one reagent containing a) nuclease for digesting single-stranded RNA and b) a nucleic acid precipitating carrier agent, (sheared DNA or linear acrylamide). A second reagent contains a chaotropic agent (a guanidinium salt) for inactivating said nucleases and an alcohol (ethanol or isopropanol) for the simultaneous inactivation of the nucleases and the precipitation of the nucleic acids without the need for protease digestion or organic extraction.
    Type: Grant
    Filed: July 3, 1991
    Date of Patent: June 6, 1995
    Assignee: Ambion, Inc.
    Inventors: Marianna Goldrick, Matthew Winkler
  • Patent number: 5256555
    Abstract: The present invention relates to compositions and methods for increasing the yields of polynucleotide synthetic reactions. In particular, it relates to an improved reaction mixture for use in in vitro RNA transcription and in various other enzymatic reactions in which a polynucleotide is synthesized. The reaction mixture uses high concentrations of total nucleotides, in the order of 12 mM to 40 mM, i.e. levels that were previously thought to be inhibitory. Other useful modifications are also disclosed.
    Type: Grant
    Filed: December 20, 1991
    Date of Patent: October 26, 1993
    Assignee: Ambion, Inc.
    Inventors: Susan C. Milburn, Marianna Goldrick, Matthew Winkler